SYN-1,2-EPOXY-1,2,3,4,15,16-HEXAHYDRO-TRANS-3,4-DIHYDROXYCYCLOPENTA-[A]-PHENANTHRENE-17-ONE
Compound with spectra: 1 NMR
![SYN-1,2-EPOXY-1,2,3,4,15,16-HEXAHYDRO-TRANS-3,4-DIHYDROXYCYCLOPENTA-[A]-PHENANTHRENE-17-ONE](/api/compound/7QLc2D5QUtI.png?ph=true&h=300&w=458 "SYN-1,2-EPOXY-1,2,3,4,15,16-HEXAHYDRO-TRANS-3,4-DIHYDROXYCYCLOPENTA-[A]-PHENANTHRENE-17-ONE")
| SpectraBase Compound ID | 7QLc2D5QUtI |
|---|---|
| InChI | InChI=1S/C17H14O4/c18-12-6-5-7-8-1-4-11-13(10(8)3-2-9(7)12)16-17(21-16)15(20)14(11)19/h1-4,14-17,19-20H,5-6H2/t14-,15+,16+,17-/m1/s1 |
| InChIKey | YEQANZJNVPCYRD-LTIDMASMSA-N |
| Mol Weight | 282.3 g/mol |
| Molecular Formula | C17H14O4 |
| Exact Mass | 282.089209 g/mol |
| Enantiomer InChIKey | YEQANZJNVPCYRD-HZMVEIRTSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
Chryseno[3,4-b]oxirene-1,2-diol, 1,2,2a,3a-tetrahydro-10-methyl-, (1.alpha.,2.beta.,2a.alpha.,3a.alpha.)-
(1S,2R,3S,4R)-3,4-Dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(c,H)acridine
(3S,4S)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-3,4,15,16-tetrahydrocyclopenta[a]phenanthren-17-one
3,4,15,16-TETRAHYDRO-TRANS-3,4-BIS-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-CYCLOPENTA-[A]-PHENANTHRENE-17-ONE
N-DEMETHYL-MASONINE
12-ACETOXY-16,17-DIHYDROXY-8,11,13-TRIENE-19-DEHYDROABIETIC ACID
2-[(1S,3S)-1-butyl-10-hydroxy-6,9-diketo-7-methylamino-3,4-dihydro-1H-benzo[g]isochromen-3-yl]acetic acid
cis-5-Methyl-11H-4b,10b-dihydro[1]benzopyrano[4,3-c]isoquinoline-6,11(5H)-dione
1-Phenanthrenecarboxylic acid, 7-bromo-6-[(diethoxyphosphinyl)oxy]-1,2,3,4,4a,9,10,10a-octahydro-1,4 a-dimethyl-, methyl ester, [1S-(1.alpha.,4a.alpha.,10a.beta.)]-
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of the putative active metabolites of the cyclopenta[a]phenanthrenes. Synthesis of the trans-3,4-dihydro-3,4-diol and syn-3,4-diol 1,2-epoxide derivatives of the mutagen 15,16-dihydrocyclopenta[a]phenanthren-17-one | The Journal of Organic Chemistry | 1992 |